Shine secures Dutch approval for terbium isotope development grant

By staff writers

October 21, 2022 -- Shine Technologies has secured approval from the Dutch government for a grant proposal to develop terbium isotopes for nuclear medicine imaging.

The company will work with the University Medical Center Groningen (UMCG) and Delft University of Technology (TU Delft) to develop a supply chain for terbium-based nuclear medicine. The isotopes show promise for diagnosing and treating cancer, but their use has been blocked by a lack of raw materials and complicated processing technology, the company said. Shine's collaboration with UMCG and TU Delft will resolve these issues, according to the firm.

Shine is currently building a medical isotope production facility at its campus in Janesville, WI, which it expects to start up in 2023.

Copyright © 2022

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking